Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma-Reference-Cited by-同舟云学术

Pharmacokinetic optimitzation of CCG-203971: Novel inhibitors of the Rho/MRTF/SRF transcriptional pathway as potential antifibrotic therapeutics for systemic scleroderma

Published:2017-04 Issue:8 Volume:27 Page:1744-1749
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Hutchings Kim M.,Lisabeth Erika M.,Rajeswaran Walajapet,Wilson Michael W.,Sorenson Roderick J.,Campbell Phillip L.,Ruth Jeffrey H.,Amin Asif,Tsou Pei-Suen,Leipprandt Jeffrey R.,Olson Samuel R.,Wen Bo,Zhao Ting,Sun Duxin,Khanna Dinesh,Fox David A.,Neubig Richard R.,Larsen Scott D.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference18 articles.

1. Fibrosis under arrest;Wynn;Nat Med,2010

2. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling;Hinz;Am J Pathol,2012

3. Emerging targets for the treatment of scleroderma;Leask;Expert Opin Emerg Drugs,2012

4. Into the matrix: targeting fibroblasts in pulmonary fibrosis;Sivakumar;Curr Opin Pulm Med,2012

5. Linking actin dynamics and gene transcription to drive cellular motile functions;Olson;Nat Rev Mol Cell Biol,2010

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Inhibitors of Rho/MRTF/SRF Transcription Pathway Regulate Mitochondrial Function;Cells;2024-02-24

3. Pharmacological prevention of fibrosis in dacryosurgery;Russian Annals of Ophthalmology;2024

4. Aza‐Heterocyclic Building Blocks with In‐Ring CF₂‐Fragment;The Chemical Record;2023-10-24

5. Novel approaches to target fibroblast mechanotransduction in fibroproliferative diseases;Pharmacology & Therapeutics;2023-10